Regeneron Pharmaceuticals | REGN - Employees Total Number

Stock Price
738.49
Daily Change
-27.53 -3.59%
Monthly
-0.43%
Yearly
23.13%
Q2 Forecast
734.06

Regeneron Pharmaceuticals reported 13.45K in Employees for its fiscal year ending in December of 2023.





Employees Change Date
AbbVie 55K 5K Dec/2024
Agenus 389 144 Dec/2023
Agios Pharmaceuticals 486 103 Dec/2024
Alnylam Pharmaceuticals 2.23K 130 Dec/2024
Amgen 28K 1.3K Dec/2024
Astellas Pharma 13.64K 1.11K Dec/2025
AstraZeneca USD 89.9K 6.4K Dec/2023
Biogen 7.6K 35 Dec/2024
BioMarin Pharmaceutical 3.04K 361 Dec/2024
Bristol-Myers Squibb 34.1K 0 Dec/2024
Eli Lilly 47K 4K Dec/2024
Esperion Therapeutics 240 41 Dec/2023
Gilead Sciences 17.6K 400 Dec/2024
GlaxoSmithKline 69.4K 20.7K Dec/2022
Incyte 2.62K 93 Dec/2024
Ionis Pharmaceuticals 1.07K 142 Dec/2024
J&J 138.1K 6.2K Dec/2024
Kyowa Hakko Kirin 5.67K 305 Dec/2024
Merck 75K 3K Dec/2024
Moderna 5.8K 200 Dec/2024
Neurocrine Biosciences 1.8K 400 Dec/2024
Novartis USD 101.7K 2.62K Dec/2022
Novartis 101.7K 2.62K Dec/2022
Pfizer 81K 7K Dec/2024
Puma Biotechnology 185 7 Dec/2023
Regeneron Pharmaceuticals 13.45K 1.6K Dec/2023
Roche Holding 103.61K 2.69K Dec/2022
Sanofi EUR 91.57K 3.87K Dec/2022
Sarepta Therapeutics 1.37K 58 Dec/2024
Ultragenyx Pharmaceutical 1.29K 18 Dec/2024
United Therapeutics 1.3K 137 Dec/2024
Vertex Pharmaceuticals 6.1K 700 Dec/2024